The effect of zinc supplementation on the treatment of chronic hepatitis C patients with interferon and ribavirin

Clinical Biochemistry

Volumn 38, Issue 7, 2005, Pages 614-620

  Ko, Wang Sheng ^a,b   Guo, Chih Hung ^a   Hsu, Guoo Shyng W ^c   Chiou, Ya Ling ^b   Yeh, Maw Sheng ^a   Yaun, Shyu Rong ^d  

^a HUNGKUANG UNIVERSITY   (Taiwan)

^b KUANG TIEN GENERAL HOSPITAL   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Adverse side effect; Chronic hepatitis C; Interferon ribavirin; Serum zinc and copper; Zinc supplement

Indexed keywords

ALPHA2A INTERFERON; COPPER; GLUCONATE ZINC; RECOMBINANT ALPHA2A INTERFERON; RIBAVIRIN; ROBATROL; ZINC;

ADULT; ANXIETY; ARTHRALGIA; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPPER BLOOD LEVEL; DEPRESSION; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG EFFECT; DRUG RESPONSE; DRUG TOLERABILITY; FATIGUE; FEMALE; FEVER; FLU LIKE SYNDROME; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HEADACHE; HEMOLYTIC ANEMIA; HEPATITIS C; HUMAN; INSOMNIA; IRRITABILITY; LEUKOPENIA; MALE; MYALGIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT REDUCTION; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

ADULT; DRUG THERAPY, COMBINATION; FEMALE; GLUCONATES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; RIBAVIRIN; ZINC;

EID: 21844441882     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2005.04.003     Document Type: Article

References (62)

1. J.G. McHutchison, S.C. Gordon, and E.R. Schiff Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C N. Engl. J. Med. 339 1998 1485 1492
2. C. Vandelli, F. Renzo, and E. Lovato Interferon versus ribavirin plus interferon in chronic hepatitis C patients relapsers and non responders to recombinant interferon J. Hepatol. 28 Suppl. 1 1998 120
3. E. Barnes, G. Webster, R. Jacobs, and G. Dusheiko Long-term efficacy of treatment of chronic hepatitis C with alpha interferon or alpha interferon and ribavirin J. Hepatol. 31 Suppl. 1 1999 244 249
4. B.E. Gilbert, and V. Knight Biochemistry and clinical applications of Ribavirin Antimicrob. Agents Chemother. 30 1986 201 205
5. J.B. McCormick, I.J. King, and P.A. Webb Lassa fever: effective treatment with Ribavirin N. Engl. J. Med. 314 1986 20 26
6. J.H. Hoofnagele Management of hepatitis C: current and future perspectives J. Hepathol. 31 Suppl. 1 1999 264 268
7. S.R. Goldstein, F.P. Martino, and S. Cort Ribavirin capsules (SCH 18908) investigator's brochure Schermg-Plough Research Institute 1997
8. O. Reichard, R. Schvarcz, and O. Weiland Therapy of hepatitis C: alpha interferon and ribavirin Hepatology 26 3 Suppl. 1 1997 108S 111S
9. C. Loguercio, V. de Girolamo, and A. Fedelicio Trace element and chronic liver diseases J. Trace Elem. Med. Biol. 11 1997 158 161
10. J.L. Poo, R.R. Romero, and J.A. Robles Diagnostic value of the copper/zinc ratio in digestive cancer: a case control study Arch. Med. Res. 28 1997 259 263
11. M. Zowczak, M. Iskra, L. Torliski, and S. Cofta Analysis of serum copper and zinc concentrations in cancer patients Biol. Trace Elem. Res. 82 2001 1 8
12. J.L. Poo, R. Rosas-Romero, A.C. Montemayor, F. Isoard, and M. Uribe Diagnostic value of the copper/zinc ratio in hepatocellular carcinoma: a case control study J. Gastroenterol. 38 2003 45 51
13. I. Halifeoglu, B. Gur, S. Aydin, and A. Ozturk Plasma trace elements, vitamin B12, folate, and homocysteine levels in cirrhotic patients compared to healthy controls Biochemistry (Mosc.) 69 2004 693 696
14. I. Meram, F. Sirmatel, S. Ahi, and M. Tarakcioglu Plasma copper and zinc levels in chronic viral hepatitis Saudi Med. J. 25 2004 1066 1069
15. T. Nagamine, H. Takagi, and Y. Hashimoto The possible role of zinc and metallothionein in the liver on the therapeutic effect of IFN-alpha to hepatitis C patients Biol. Trace Elem. Res. 58 1997 65 76
16. T. Nagamine, H. Takagi, and H. Takayama Preliminary study of combination therapy with interferon-α and zinc in chronic hepatitis C patients with genotype 1 b Biol. Trace Elem. Res. 75 2000 53 63
17. C. Loguercio, V. de Girolamo, and A. Federico Relationship of blood trace elements to liver damage, nutritional status, and oxidative stress in chronic nonalcoholic liver disease Biol. Trace Elem. Res. 81 2001 245 254
18. M. Ratka, M. Lackmann, C. Ueckermann, U. Karlins, and G. Koch Poliovirus-associated protein kinase: destabilization of the virus capsid and stimulation of the phosphorylation reaction by Zn+2 J. Virol. 63 1989 3954 3960
19. Z.Y. Zhang, I.M. Reardon, and J.O. Hui Zinc inhibition of rennin and the protease from human immunodeficiency virus type I Biochemistry 10 1991 8717 8721
20. Y. Haraguchi, H. Sakurai, and S. Hussain Inhibition of HIV-1 infection by zinc group metal compounds Antivur. Res. 43 1999 123 133
21. O.S. Rahaman Jr., and E.C. James Effect of zinc salts on respiratory syncytial virus replication Antimicrob. Agents Chemother. 48 2004 783 790
22. H. Takagi, T. Nagamine, and T. Abe Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C J. Viral Hepatitis 8 2001 367 371
23. G.W. Evans Zinc and its deficiency disease Clin. Physiol. Biochem. 4 1986 94 98
24. P.F. Renault, and J.H. Hoofnagele Side effects of alpha interferon Semin. Liver Dis. 9 1989 273 281
25. J.E. Sprietsma Zinc-controlled Th1/Th2 switch significantly determines development of diseases Med. Hypotheses 49 1997 1 14
26. C.H. Guo, C.J. Huang, Y.L. Chiou, and G-S.W. Hsu Alteration of trace element distribution and testis ACE activity in mice with high peritoneal aluminum Biol. Trace Elem. Res. 86 2002 145 157
27. Ko WS, Guo CH, Yeh MS, Lin LY, Hsu G-SW, Chen PC, Luo MC, Lin CY. Blood micronutrients, oxidative stress, and viral loads in patients with chronic hepatitis C. World J. Gastoenterol. 11 [in press].
28. M.A. Selimoǧlu, S. Aydoǧdu, F. Anal, G. Yuce, and R.V. Yaǧci Serum zinc status in chronic hepatitis B and its relationship to liver histology and treatment results Pediatr. Intern. 43 2001 396 399
29. C. Pramoolsinsap, N. Promvanit, S. Komindr, P. Lerdverasirikul, and S. Srianujata Serum trace metals in chronic viral hepatitis and hepatocellular carcinoma in Thailand J. Gastroenterol. 29 1994 610 615
30. K. Suzuki, R. Oyama, E. Hayashi, and Y. Arakawa Liver diseases and essential trace elements Nippon Rinsho 54 1996 85 92
31. A. Kalkan, V. Bulut, S. Avci, I. Celik, and N.K. Bingol Trace elements in viral hepatitis J. Trace Elem. Med. Biol. 16 2002 227 230
32. C. Pramoolsinsap, N. Promvanit, and S. Kurathong Serum trace metal levels in patients with acute hepatitis B Southeast Asian J. Trop. Med. Public Health 27 1996 476 480
33. F. Rodriguez-Moreno, E. Gonzalez-Reimers, and F. Santolaria-Fernandez Zinc, copper, manganese and iron in chronic alcoholic liver disease Alcohol 14 1997 39 44
34. C.T. Wang, W.T. Chang, T.M. Pan, and R.T. Wang Blood concentrations of selenium, zinc, iron, copper and calcium in patients with hepatocellular carcinoma Clin. Chem. Lab. Med. 40 2002 1118 1122
35. M. Sato, J. Yamaki, and T. Oguro Metallothionein synthesis induced by interferon alpha/beta in mice of various zinc status Tohoku J. Exp. Med. 178 1996 241 250
36. R.J. Cousins Absorption, transport and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin Physiol. Rev. 65 1985 238 309
37. L.S. Valberg, P.R. Flanagan, C.N. Ghent, and M.J. Chamberlain Zinc absorption and leucocyte zinc in alcoholic and nonlcoholic cirrhosis Dig. Dis. Sci. 30 1985 329 333
38. I. Grattagliano, S. Russmann, V.O. Palmieri, P. Juni, F. Bihl, P. Portincasa, G. Palasciano, and B.H. Lauterburg Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C Heapatology 39 2004 1248 1255
39. F. Morisco, V. Verde, V. Foyliano, A. Ritieni, R. Marmo, G. De Luise, C. Tuwcillo, and N. Caporaso Oxidative stress in chronic hepatitis C: the influence of antiviral therapy and prognostic value of serum hyproperoxide assay Free Radic. Res. 38 2004 573 580
40. P.M. Hanna, M.B. Kadiiska, S.J. Jordan, and R.P. Mason Role of metallothionein in zinc and chromium mediated tolerance to carbon tetrachloride hepatotoxicity: evidence against a trichloromethyl radical scavenging mechanism Chem. Res. Toxicol. 6 1993 711 717
41. A. Gimenez, A. Pares, and S. Alie Fibrogenic and collagenolytic activity in carbon-tetrachloride-injured rats: beneficial effects of zinc administration J. Hepatol. 21 1994 292 298
42. M. Cabre, J. Folch, and A. Gimenez Influence of zinc intake on hepatic lipid peroxidation and metallothioneins in alcoholic rats: relationship to collagen synthesis Int. J. Vitam. Nutr. Res. 65 1995 45 50
43. S.R. Powell The antioxidant properties of zinc J. Nutr. 130 2000 1447S 1454S
44. A. Fleck, and M.A. Myers Diagnostic and prognostic significance of the acute-phase proteins A.H. Gordon A. Koj The acute-phase response to injury and infection 1985 Elsevier Amsterdam, Netherlands 249 271
45. A. Koyanagi, D. Kuffo, and L. Gresely Relationships between serum concentrations of C-reactive protein and micronutrients, in patients with tuberculosis Ann. Trop. Med. Parasitol. 98 2004 391 399
46. C. Mayland, K.R. Allen, T.J. Degg, and M. Bennet Micronutrient concentrations in patients with malignant disease: effect of the inflammatory response Ann. Clin. Biochem. 41 Pt 2 2004 138 141
47. E. Akcil, G. Yavuz, and M. Kocak Effects of inflammation and anti- inflammatory treatment on serum trace elements concentrations Biol. Trace Elem. Res. 93 2003 95 104
48. M. Maes, E. Vandoolaeghe, and H. Neels Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness Biol. Psychiatry 42 1997 349 358
49. S. Sazawal, P. Malik, and S. Jalla Zinc supplementation for four months does not affect plasma copper concentration in infants Acta Paediatr. 93 2004 599 602
50. Y. Arakawa, K. Suzuki, and S. Takeuchi Zinc status in liver and gastrointestinal diseases J. Nutr. Sci. Vitaminol. 1992 526 529
51. H. Tashiro, T. Kawamoto, T. Okubo, and O. Koide Variation in distribution of trace elements in hepatom Biol. Trace Elem. Res. 95 2003 49 62
52. S.G. Novick, J.C. Godfrey, R.L. Pollack, and H.R. Wilder Zinc-induced suppression of inflammation in the respiratory tract, caused by infection with human rhinovirus and other irritants Med. Hypotheses 49 1997 347 357
53. A.S. Prasad Zinc and immunity Mol. Cell Biochem. 188 1998 63 69
54. R. Radhakrishnan, L.J. Walter, and A. Hruza Zinc mediated dimer of human interferon-alpha 2 b revealed by X-ray crystallography Structure 4 1996 1453 1463
55. J. Van Weyenbergh, G. Santana, and A. D'Oliveira Jr. Zinc/copper imbalance reflects immune dysfunction in human leishmaniasis: an ex vivo and in vitro study BMC Infect. Dis. 4 2004 50 57
56. S.W. Schalm, O. Weiland, and B.E. Hansen Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials Gastroenterology 117 1999 408 413
57. D. Kumar, C. Wallington-Beddoe, J. George, and R. Lin Effectiveness of interferon alfa-2b/ribavirin combination therapy for chronic hepatitis C in a clinic setting MJA 178 2003 267 271
58. H. Takagi, K. Takehara, and R. Shimoda Prediction of the effect of interferon on chronic hepatitis C Dig. Dis. Sci. 42 1997 2270 2276
59. F. Piccinino, F.M. Felaco, and E. Sagnelli Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicenter study on dose and duration of IFN alpha treatment Res. Virol. 149 1998 283 291
60. J.B. Wong, G.L. Davis, and S.G. Pauker Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C Am. J. Med. 108 2000 366 373
61. S. Takaki, A. Tsubota, and T. Hosaka Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C J. Gastroenterol. 39 2004 668 673
62. H. Gonzalez, M.E. Rios, and E.A. Torres Folic acid supplementation does not prevent ribavirin-induced anemia P. R. Health Sci. J. 22 2003 359 362